← Back to Patent Explorer
US4108983A Expired / Lapsed US ⏱️ 0.0 years remaining

Viral oncolysate vaccine for stimulating the immune mechanism of mammals to species-specific tumors

Assignee: The Wistar Institute
•
Filing: 1976-06-01
•
Granted: 1978-08-22
•
Expires: 1996-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A virus-lysed tumor cell vaccine is an active immunotherapeutic agent against tumors in mammals. In particular, a vaccine based upon vaccinia virus-lysed, species-specific tumor cells is an effective stimulator of the immune response in mammals, and a vaccine based upon vaccinia virus-lysed spontaneously arising tumor cells is an effective stimulator of the immune response in some human cancer patients. A process for preparing the vaccine by viral oncolysis is also disclosed. Tumor cells are removed from a mammal, the cells are cultured in a culture medium and infected with live vaccinia virus. Viral oncolysis occurs during incubation and the resulting viral oncolysate, after extraction, may be injected into mammals to stimulate the immune response mechanism.

Inventors

  • 👤 Marc K. Wallack

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 04:03
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/0005; A61K39/0011

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 74 words
A method of forming a vaccine capable of stimulating the immune mechanism of mammals to species-specific tumors comprising infecting cells of a species-specific tumor in vitro with a virus having a lytic action on the cells of said tumor, said virus comprising vaccinia virus and being substantially less pathogenic for said mammal than is said tumor, maintaining said virus infected cells under culture conditions until a viral oncolysate is formed and harvesting said oncolysate.
Claim 2
Independent Claim 74 words
A method of forming a vaccine capable of stimulating the immune mechanism of mammals to species-specific tumors comprising infecting cells of a species-specific tumor in vitro with a virus having a lytic action on the cells of said tumor, said virus comprising vaccinia virus and being substantially less pathogenic for said mammal than is said tumor, maintaining said virus infected cells under culture conditions until a viral oncolysate is formed and harvesting said oncolysate.
Claim 3
Dependent Claim 13 words
The method of claim 1 wherein said tumor is a spontaneous malignant tumor.
Claim 4
Dependent Claim 10 words
The method of claim 1 wherein said mammal is man.
Claim 5
Dependent Claim 15 words
The method of claim 1 wherein said virus infected cells are maintained in suspension culture.
Claim 6
Dependent Claim 15 words
The method of claim 2 wherein said virus infected cells are maintained in suspension culture.
Claim 7
Dependent Claim 64 words
A vaccine for stimulating the immune mechanism of mammals to species-specific tumors, said vaccine comprising the viral oncolysate of a species-specific tumor and a virus having a lytic action on the cells of said tumor, said virus comprising vaccinia virus and being substantially less pathogenic for said mammal than is said tumor, said viral oncolysate being the product of an in vitro oncolysis reaction.
Claim 8
Dependent Claim 64 words
A vaccine for stimulating the immune mechanism of mammals to species-specific tumors, said vaccine comprising the viral oncolysate of a species-specific tumor and a virus having a lytic action on the cells of said tumor, said virus comprising vaccinia virus and being substantially less pathogenic for said mammal than is said tumor, said viral oncolysate being the product of an in vitro oncolysis reaction.
Claim 9
Dependent Claim 10 words
The vaccine of claim 6 wherein said mammal is man.
Claim 10
Dependent Claim 15 words
The vaccine of claim 6 prepared in vitro in suspension culture of said tumor cells.
Claim 11
Dependent Claim 13 words
The vaccine of claim 6 wherein said tumor is a spontaneous malignant tumor.
Claim 12
Dependent Claim 15 words
The vaccine of claim 7 prepared in vitro in suspension culture of said tumor cells.
Claim 13
Independent Claim 80 words
A method of stimulating the immune mechanism of mammals to species-specific tumors comprising removing tumor tissue from a species of said mammal and growing tumor cells of said tissue in a culture medium, infecting said cells with a virus capable of lysing said cells, said virus comprising vaccinia virus and being less pathogenic for said mammal than is said tumor, culturing said cells and virus until oncolysis occurs and injecting the viral oncolysate into a mammal of the same species.
Claim 14
Independent Claim 80 words
A method of stimulating the immune mechanism of mammals to species-specific tumors comprising removing tumor tissue from a species of said mammal and growing tumor cells of said tissue in a culture medium, infecting said cells with a virus capable of lysing said cells, said virus comprising vaccinia virus and being less pathogenic for said mammal than is said tumor, culturing said cells and virus until oncolysis occurs and injecting the viral oncolysate into a mammal of the same species.
Claim 15
Dependent Claim 15 words
The method of claim 11 wherein said tumor cells are suspended in said culture medium.
Claim 16
Dependent Claim 10 words
The method of claim 11 wherein said mammal is human.
Claim 17
Dependent Claim 10 words
The method of claim 12 wherein said mammal is human.
Claim 18
Dependent Claim 28 words
The method of claim 11 wherein said mammal into which the viral oncolysate is injected bears a tumor of the same variety from which the oncolysate is prepared.
Claim 19
Dependent Claim 31 words
The method of claim 15 wherein said tumor tissue removed is an autochthonous tumor and said viral oncolysate is injected into the same mammal from which said tumor tissue is obtained.
Claim 20
Dependent Claim 10 words
The method of claim 16 wherein said mammal is human.

References Cited (Backward Citations)

US3553312A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-08-21 1982-02-20 1982-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-08-21 1986-02-20 1986-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-08-21 1990-02-20 1990-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag